PND34 - PAYER AND SOCIETAL BENEFIT OF PEGINTERFERON BETA-1A VERSUS GLATIRAMER ACETATE IN PATIENTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS IN SPAIN
Oct 1, 2018, 00:00
10.1016/j.jval.2018.09.2001
https://www.valueinhealthjournal.com/article/S1098-3015(18)35303-8/fulltext
Title :
PND34 - PAYER AND SOCIETAL BENEFIT OF PEGINTERFERON BETA-1A VERSUS GLATIRAMER ACETATE IN PATIENTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS IN SPAIN
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)35303-8&doi=10.1016/j.jval.2018.09.2001
First page :
Section Title :
Open access? :
No
Section Order :
1353